Navigation Links
Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
Date:4/23/2012

FARMINGTON, Conn., April 23, 2012 /PRNewswire-iReach/ -- Global Information Inc. is announces limited time remaining to purchase Early Bird discounted registration for three important Boston healthcare conferences:

Next-Gen Kinase Inhibitors 2012

Pioneers from across the rapidly maturing kinase inhibitors field will gather to explore the exciting question of what lies ahead at the Next-Gen Kinase Inhibitors Conference in Cambridge, MA. What is in store for the pharmaceutical industry and what new avenues are opening up for new technologies and methods as novel targets and therapeutic approaches are explored? What ground-breaking kinase indications are being discovered, and what other therapeutic areas are blossoming? Topics include key issues around addressing resistance; selectivity versus safety; developing lead compounds; the integration of chemistry and biology, and much more.

Save up to $200 by registering before April 27! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214653-2012/

Structure-Based Drug Design Conference 2012

Structure-based drug design took nearly two decades of multiple, parallel technological improvements to arrive at its current mainstream position in medicinal chemistry. At the 12th Annual Structure-Based Drug Design Conference in Cambridge, MA an accomplished faculty of experts will bring to focus recent advancements in this evolving and dynamic field. Attendees will learn about developments in computer graphics, high-power radiation sources, computational processing power, refinement protocols, virtual screening and crystallography, all technolgies that are absolutely necessary to crea
'/>"/>

SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Chemist to donate potential pharmaceutical royalties to Madagascar
2. Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
3. Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference
4. Simulating pharmaceutical and personal care product transport
5. Researchers prolong the half-life of biopharmaceutical proteins
6. InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T Technology for production of recombinant proteins
7. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. NIH awards $8.5 million for research on pharmaceuticals for children
10. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
11. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... According to a new ... Software, Services), by Applications (Surveillance (Airborne, Maritime, Land), ... (Military & Defense & Commercial) - Global Forecast ... is expected to grow from $7252.0 Million in ... Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... 3D-ID LLC, a company engaged in biometric identification is ... technology portion of the recently awarded TIES (Technical Information ... the Army. 3D-ID LLC has a suite ... enforcement and security agencies. Gino Pereira ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Global Genetic Testing Market Outlook 2018 2
... that fish tend to return to the same river where ... State University have determined that the old rule doesn,t always ... Using a statistical analysis of chemicals found in walleye ear ... walleye hatched in the Sandusky and Maumee rivers that returned ...
... scientist has discovered what could be the world,s rarest coral ... elkhorn coral was found while conducting underwater surveys of Arno ... Richards of the ARC Centre of Excellence for Coral Reef ... to the critically endangered and fast-vanishing elkhorn coral ( Acropora ...
... in the 29 July issue of the international journal ... algae known as "phytoplankton" have been declining globally over the ... chain and sustains diverse assemblages of species ranging from tiny ... author Daniel Boyce, "Phytoplankton is the fuel on which marine ...
Cached Biology News:Ear bones reveal spawning secrets of Lake Erie walleye 2Ear bones reveal spawning secrets of Lake Erie walleye 3Ear bones reveal spawning secrets of Lake Erie walleye 4Super-rare 'elkhorn' coral found in Pacific 2Super-rare 'elkhorn' coral found in Pacific 3New study reveals decline of marine phytoplankton over the past century 2
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... Patent Offering, The patent’s technology pertains ... therapeutic imaging within a body lumen (open space). ... a low cost, single-use disposable illumination and camera module ... 18, 2013 and the patent approval was received on ... to customize the lighting and magnification of the endoscope ...
(Date:5/21/2015)... May 21, 2015 /PRNewswire/ - RepliCel Life Sciences ... regenerative medicine company focused on the development of ... presentation at the International Society for Cellular Therapy ... Achilles tendinosis currently in a Phase 1/2 clinical ... th from 5:30 PM to 7:00 PM ...
(Date:5/20/2015)... DUBLIN , May 20, 2015 Research and ... addition of the "Top Technologies in HW_Technical Insights" ... division of this report evaluated technology trends in the ... trends that are likely to have an impact in ... depth analysis of the top 10 health and wellness ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Top Technologies in the Health and Wellness Industry 2015 2
... Pivotal Study in, Rituximab Refractory Follicular Non-Hodgkin,s lymphoma ... Number ... Genmab A/S (OMX:,GEN) announced today it has amended the design ... follicular,non-Hodgkin,s lymphoma (NHL) to a single arm trial that will ...
... May Help Increase Appropriate Early Use in Acute Coronary Syndrome ... ... 27 ,Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb,Company (NYSE: ... approved a supplemental new drug application,(sNDA) for a 300mg tablet of the ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... commercializing proprietary product candidates for the treatment,of ... data from,preclinical studies of ANX-514 (docetaxel emulsion) ... Cancer Research (AACR), National Cancer,Institute (NCI) and ...
Cached Biology Technology:Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 2Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 3FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate) 2FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate) 3FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate) 4FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate) 5ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 2ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 4
... Collect eliminates manual data entry by ... into any Windows-based application. Collect is ... countless hours of tedious data entry. ... balances, scales, pH meters, spectrophotometers, force gauges, ...
... autofluorescent pigment lipofuscin accumulates in the ... neurons. The presence of lipofuscin granules ... microscopy in the central nervous system ... emission spectra, which overlaps with those ...
DNA sequencing - plasmids or PCR fragments, 3-7 working days service....
Polyclonal Antibody to Golgin-67...
Biology Products: